‘Bad cholesterol’ is targeted as possible catalyst among those with early-onset Alzheimer’s
By
John O'Connor
May 31, 2019
While most people with Alzheimer’s disease are 80 years old or older, about 10% begin to suffer symptoms before age 65.
Residents need quicker access to helpful medicines and devices
By
John O'Connor
May 27, 2019
There is much to admire about the march of clinical innovation. Yet it remains hampered by one thing: ridiculous delay. By some estimates, 17 years typically elapse between the time of medical discovery...
SNFs enjoy more fruits from Trump’s labors
By
John O'Connor
May 06, 2019
When I began covering this field nearly three decades ago, administrators were more afraid of employee unionization than just about anything else. But times have changed.
A PDPM tool that’s flying under the radar
By
John O'Connor
Feb 19, 2019
We are hearing much these days about the government’s plan to adjust Medicare payments. But not much is being said about a helpful resource that could spell the difference between success and failure.
The right prescription?
By
John O'Connor
Nov 02, 2018
If you want to know what skilled care will look like in five years, consider what hospitals look like today. The first time I heard that adage was in 1990. These days, it rings truer than ever. To be sure,...
Might there be a drug company in your future?
By
John O'Connor
Sep 13, 2018
If you want to know what skilled care will look like in five years, consider what hospitals look like today.
Fire, rain and the elephant on the 40th floor
By
John O'Connor
Nov 27, 2017
You never know when freak storms or unexpected fires might strike. But you can be sure that if and when one does, angry people will line up to demand that you be held more accountable.
Is it time for operators to focus on small ball?
By
John O'Connor
Oct 02, 2017
Rick Matros tweaked more than a few noses last week when he made some rather disparaging remarks about the benefits of investing in behemoths. As he sees it, there pretty much are none.
Alzheimer’s drug maker sends a different message in the courtroom
By
John O'Connor
May 08, 2015
It’s almost impossible to turn on the tube these days without seeing an ad from a drug company. The typical scenario goes something like this: Person with a disease or problem is all smiles, thanks...
Our government is a terrible thing — to hate (and a thank-you)
By
John O'Connor
Apr 17, 2015
Providers are finding their personal and professional relationships with the government tested these days. But before we all grab our torches and pitchforks, let’s take a deep breath.